LTR Pharma Ltd News

LTR Pharma Ltd: Reinstatement to quotation

Jun 6 21:39 ET

LTR Pharma Ltd: SPONTAN achieves positive clinical study results

Jun 6 21:39 ET

LTR Pharma Ltd: Suspension from Quotation

Jun 5 20:42 ET

LTR Pharma Ltd: Trading Halt

Jun 3 19:11 ET

LTR Pharma Ltd: Response to ASX Price Query

May 22 01:44 ET

LTR Pharma Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 28 19:38 ET

LTR Pharma Ltd: Notification regarding unquoted securities - LTP

Apr 18 02:59 ET

LTR Pharma Ltd: Final Patients dosed in SPONTAN pivotal study

Mar 24 18:05 ET

LTR Pharma Ltd: First patients dosed in SPONTAN pivotal study

Mar 18 17:45 ET

LTR Pharma Ltd: Investor Presentation

Mar 17 17:32 ET

LTR Pharma Ltd: Appendix 4D and Half Yearly Report

Feb 27 16:10 ET

LTR Pharma Ltd: Recruitment commences for SPONTAN Clinical Study

Feb 18 16:11 ET

LTR Pharma Ltd: Notification regarding unquoted securities - LTP

Feb 15 17:15 ET

LTR Pharma Ltd: SPONTAN Achieves Key Manufacturing Validation

Feb 5 16:23 ET

LTR Pharma Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jan 29 16:16 ET

LTR Pharma Ltd: Response to ASX Query Letter

Dec 19, 2023 01:53 ET

LTR Pharma Ltd: Positive Clinical Data presented at the WMSM in Dubai

Dec 17, 2023 17:26 ET

LTR Pharma Ltd: Initial Director's Interest Notice - M McGuire

Dec 12, 2023 18:35 ET

LTR Pharma Ltd: Initial Director's Interest Notice - J Chick

Dec 12, 2023 18:32 ET

LTR Pharma Ltd: Initial Director's Interest Notice - L Rodne

Dec 12, 2023 18:31 ET